NNOX Nano X Imaging

Nanox to Report First Quarter and Financial Results on May 28, 2024

Nanox to Report First Quarter and Financial Results on May 28, 2024

PETACH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2024, before market open on Tuesday, May 28, 2024. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Interested parties may register for the conference call using the following link:  . You may access the live webcast of the conference call by using the following link: . The link will also be posted in the Investor Relations section of the Nanox website at .

About Nanox

Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox’s vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease (Nanox.AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE). Together, Nanox’s products and services create a worldwide, innovative, and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit 

Contacts

Media Contact:

Ben Shannon

ICR Westwicke

Investor Contact:

Mike Cavanaugh

ICR Westwicke



EN
20/05/2024

Underlying

NNOXNano X Imaging

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nano X Imaging

 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox to Report Second Quarter 2025 Financial Results on August 12, 20...

Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025 PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2025, before market open on Tuesday, August 12, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. In...

August 1, 2025 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Announces Clinical and Educational Collaboration with Keiser Uni...

Nanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARC Nanox.ARC delivers advanced 3D imaging with proprietary cold cathode technologyClinical studies show superior diagnostic performance to X-ray with reduced radiation exposure compared to CT PETACH TIKVA, Israel, July 01, 2025 (GLOBE NEWSWIRE) -- ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced a clinical and educational collaboration with , Florida’s largest private, non-profit university. The , an advanced 3D digital tomosynthe...

July 1, 2025 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Softw...

Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment HealthOST identifies vertebral height loss and bone mineral density, which are key indicators of musculoskeletal diseaseOsteoporosis is a common progressive bone disease among adults over 50 years of age that causes bones to weaken, leading to fracturesThe software provides automated quantification of vertebral parameters from routine CT scans, delivering consistent and objective data to support physician evaluation, before life-altering fractures occur PETACH TIKVA, Israel, June 05, 2025 (GLOB...

June 5, 2025 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox to Participate in Sidoti Small Cap Conference

Nanox to Participate in Sidoti Small Cap Conference Management to present on Wednesday, June 11 at 1:45 PM ET PETACH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will participate in the Sidoti Small Cap Conference to be held virtually June 11-12, 2025. Nanox management will present on Wednesday, June 11 at 1:45 PM ET. Interested parties may access a live webcast of the presentation using the following link: . The link will also be posted to the com...

June 3, 2025 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Announces First Quarter 2025 Financial Results and Provides Busi...

Nanox Announces First Quarter 2025 Financial Results and Provides Business Updates Management to host conference call and webcast on Thursday, May 22, 2025 at 8:30 AM ET PETACH TIKVA, Israel, May 22, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2025, and provided a business update. Recent Highlights: Generated $2.8 million in revenue in the first quarter of 2025, compared to $2.6 million in the first quarter of 2024.Received 510(k) c...

May 22, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch